Navigation Links
Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles
Date:9/18/2013

BLUE BELL, Pa., Sept. 18, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, will be presenting an overview of the company at the Aegis Capital Corp. Healthcare Conference and BioCentury's 20th Annual NewsMakers in the Biotech Industry Conference. He will also be the invited speaker at the Town Hall Los Angeles meeting on Tuesday, September 24, 2013. In his speech titled, "Are We Prepared for the Next Pandemic Flu Virus? Is a New Universal Vaccine the Answer," Dr. Kim will discuss the potential devastating effects of an influenza pandemic and how medicine is working urgently to meet the next pandemic.

Aegis Capital Corp. Healthcare Conference

September 25-28, 2013
The Encore at Wynn Las Vegas
Las Vegas, NV

Inovio Presentation
Thursday, September 26, 2013
8:30 AM PT

BioCentury's 20th Annual NewsMakers in the Biotech Industry Conference

September 27, 2013
Millennium Broadway Hotel
New York, NY

Inovio Presentation
Friday, September 27, 2013
11:30 AM ET

A live and archived webcast of the NewsMakers presentation will be accessible on the homepage of Inovio's website under the webcast tab at www.inovio.com.

Town Hall Los Angeles

September 24, 2013
11:30 AM -1:30 PM PT
Millennium Biltmore Hotel
Los Angeles, CA

Individuals interested in attending may register online.

About Town Hall Los Angeles
Town Hall Los Angeles is recognized as one of the Top 10 Executive Leadership Forums. They invite one compelling and newsworthy
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , Deutschland, 4. März 2015 /PRNewswire/ ... Anbieter von medizinischen Bildmanagementlösungen für Unternehmen, baut ... von Randolph Sternberg zum Director of Sales ... of Operations weiter aus. Logo ... Randolph Sternberg ist für den Verkauf ...
(Date:3/4/2015)... 4, 2015 Oramed Pharmaceuticals Inc. ... clinical-stage pharmaceutical company focused on the development of oral ... participate in the upcoming 27 th Annual ROTH ... Dana Point, CA.  Dr. Michael Berelowitz ... will present a corporate overview on March 10, 2015. ...
(Date:3/4/2015)... 2015 Perrigo Company plc (NYSE: PRGO ... Joseph C. Papa will present at the 2015 ... 11, 2015 at the Loews Miami Beach Hotel in ... presentation webcast at http://perrigo.investorroom.com/events-webcasts . From its ... Perrigo Company plc, headquartered in Ireland , ...
Breaking Medicine Technology:TeraRecon baut seine Präsenz in EMEA aus 2TeraRecon baut seine Präsenz in EMEA aus 3Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2
... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... its unaudited second quarter financial results for the period ended ... Highlights Sales increased 52.5% year-over-year to $15.7 ... shareholder reached $1.32 million and EPS was $0.02 per share. ...
... Corporation (NYSE: SHP ) ("ShangPharma" or the ... development outsourcing company, today announced that its Board of ... expects to use cash and internally generated funds to ... The board has authorized ShangPharma to buy up ...
Cached Medicine Technology:Sinovac Reports Unaudited Second Quarter 2011 Financial Results 2Sinovac Reports Unaudited Second Quarter 2011 Financial Results 3Sinovac Reports Unaudited Second Quarter 2011 Financial Results 4Sinovac Reports Unaudited Second Quarter 2011 Financial Results 5Sinovac Reports Unaudited Second Quarter 2011 Financial Results 6Sinovac Reports Unaudited Second Quarter 2011 Financial Results 7Sinovac Reports Unaudited Second Quarter 2011 Financial Results 8Sinovac Reports Unaudited Second Quarter 2011 Financial Results 9Sinovac Reports Unaudited Second Quarter 2011 Financial Results 10Sinovac Reports Unaudited Second Quarter 2011 Financial Results 11Sinovac Reports Unaudited Second Quarter 2011 Financial Results 12Sinovac Reports Unaudited Second Quarter 2011 Financial Results 13Sinovac Reports Unaudited Second Quarter 2011 Financial Results 14ShangPharma Announces Up to $10 Million Share Repurchase Program 2
(Date:3/4/2015)... 2015 Nitrosigine®, a patented complex of ... sports nutrition products, is hosting the Nitrosigine Pump Challenge ... Terrace Ballroom at The Arnold Sports Festival in Columbus, ... to March 8, 2015. , Nitrosigine is a ... Dietary Ingredient notification status; now affirmed as GRAS.^ It ...
(Date:3/4/2015)... March 04, 2015 The report “Vasculitis ... the therapeutic development for Vasculitis. Vasculitis is a disease ... cause of vasculitis diseases is not known. Vasculitis can ... range of symptoms. Symptoms can include fever, weight loss, ... a pulse in a limb. Vasculitis is treatable, but ...
(Date:3/4/2015)... The week of March 2nd - 8th ... Awareness Day being recognized on March 13th, the aim ... risks associated with sleep related illnesses, costing the United ... of America have turned to social media with an ... virally inspire conversation regarding the disease. , The ...
(Date:3/4/2015)... March 04, 2015 Follow us ... public health issue worldwide. The rising prevalence of high ... social burden in both developed and developing countries. By ... to rise to 1.5 billion, equating to approximately 30% ... patients are forecast to come from the developing countries. ...
(Date:3/4/2015)... March 04, 2015 Bird B Gone, ... and residential applications now offers its popular plastic (polycarbonate) ... humane, highly efficient bird deterrent is ready-to-use ... the color and décor of the building or structure ... red, white, crystal clear, light grey, brown, black and ...
Breaking Medicine News(10 mins):Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2
... Your ability to listen to a phone message in ... other earand comprehend what both are sayingis an ... say researchers of the National Institute on Deafness and ... of Health. ,The finding, published in the ...
... Believe it or not, Kapila, an impregnated cow of Sarnagat ... the age of two without ever getting crossed with a ... years now. ,According to the cows owner Sardar ... two-years-old and that too without ever getting pregnant. ...
... a new review of studies,School-based sexual abuse prevention programs ... increase self-protective behaviors. ,However, the programs have ... fearful of strangers, the review cautions. ,,It was ... found in the review, but we were pleased that ...
... dig into that apple or lentils, for a new study ... slowly once they have been consumed helps dieters lose more ... ,Foods that release sugars rapidly are said to ... slowly have a low glycaemic index, and Cochrane researchers led ...
... The Balehonnur-based Central Coffee Research Institute (CCRI) has said that ... market in December 2007 . ,After 21 years ... on December 15. The yet-to-be named hybrid, hi-yielding arabica variety ... less resistant to the widely prevalent white stem borer. ...
... universal influenza vaccine that has been pioneered by researchers ... the first time on humans by the British-American biotech ... intended to provide protection against all A strains of ... ,In the 1990s, VIB researchers connected ...
Cached Medicine News:Health News:Genes Influence the Ability to Listen Two Things at a Time 2Health News:Genes Influence the Ability to Listen Two Things at a Time 3Health News:School-based Sexual Abuse Prevention Programs 2Health News:School-based Sexual Abuse Prevention Programs 3Health News:Apples and Lentils Could Help You to Shed Off Those Extra Pounds! 2Health News:Human Trial for Universal Influenza Vaccine Underway 2
... is a reagent and probe system used ... high throughput plate based system is a ... a unique approach for RNA detection and ... branched DNA (bDNA) technology. Branched DNA allows ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Medicine Products: